Vanguard Fiduciary Trust
DTIL icon

Vanguard Fiduciary Trust’s Precision BioSciences DTIL Stock Holding History

Vanguard Fiduciary Trust’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.31M Buy
166,538
+10,912
+7% +$76.8K ﹤0.01% 2904
2026
Q1 		$856K Buy
+155,626
New +$718K ﹤0.01% 2992

Other funds holding DTIL

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Vanguard Fiduciary Trust's DTIL Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Precision BioSciences (DTIL) stake by 7% in Q2 2026, buying an estimated $76.8K and bringing the position to 166,538 shares worth $1.31M. The position accounts for ﹤0.01% of the portfolio, ranked #2904.

Vanguard Fiduciary Trust first reported a position in DTIL in Q1 2026 and has held it in 2 quarters since. 94 funds tracked by Wall St. Rank hold DTIL as of Q2 2026.

  • Vanguard Fiduciary Trust held 166,538 shares of Precision BioSciences worth $1.31M as of Q2 2026.
  • Vanguard Fiduciary Trust bought 10,912 Precision BioSciences shares in Q2 2026, an estimated $76.8K.
  • Precision BioSciences made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #2904 holding.
  • Vanguard Fiduciary Trust first reported a position in Precision BioSciences in Q1 2026 and has held it in 2 quarters since.
  • 94 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.